Alpha- Antitrypsin Deficiency Treatment and Forecast Market

List of Tables
Table 1. Alpha- Antitrypsin Deficiency Treatment Market Opportunities & Trends in Global Market
Table 2. Alpha- Antitrypsin Deficiency Treatment Market Drivers in Global Market
Table 3. Alpha- Antitrypsin Deficiency Treatment Market Restraints in Global Market
Table 4. Key Players of Alpha- Antitrypsin Deficiency Treatment in Global Market
Table 5. Top Alpha- Antitrypsin Deficiency Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alpha- Antitrypsin Deficiency Treatment Product Type
Table 9. List of Global Tier 1 Alpha- Antitrypsin Deficiency Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alpha- Antitrypsin Deficiency Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Alpha- Antitrypsin Deficiency Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Alpha- Antitrypsin Deficiency Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alpha- Antitrypsin Deficiency Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alpha- Antitrypsin Deficiency Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Adverum Biotechnologies, Inc. Corporate Summary
Table 31. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 32. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Alnylam Pharmaceuticals, Inc. Corporate Summary
Table 34. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 35. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Applied Genetic Technologies Corporation Corporate Summary
Table 37. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 38. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Arrowhead Pharmaceuticals, Inc. Corporate Summary
Table 40. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 41. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Carolus Therapeutics, Inc. Corporate Summary
Table 43. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 44. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Cevec Pharmaceuticals GmbH Corporate Summary
Table 46. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 47. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Dicerna Pharmaceuticals, Inc. Corporate Summary
Table 49. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 50. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Digna Biotech, S.L. Corporate Summary
Table 52. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 53. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Editas Medicine, Inc. Corporate Summary
Table 55. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 56. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Grifols, S.A. Corporate Summary
Table 58. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 59. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Inhibrx Corporate Summary
Table 61. Inhibrx Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 62. Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Intellia Therapeutics, Inc. Corporate Summary
Table 64. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 65. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 66. International Stem Cell Corporation Corporate Summary
Table 67. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 68. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Ionis Pharmaceuticals, Inc. Corporate Summary
Table 70. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 71. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Kamada Ltd. Corporate Summary
Table 73. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 74. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Polyphor Ltd. Corporate Summary
Table 76. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 77. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 78. ProMetic Life Sciences Inc. Corporate Summary
Table 79. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 80. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 81. rEVO Biologics, Inc. Corporate Summary
Table 82. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 83. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Sangamo BioSciences, Inc. Corporate Summary
Table 85. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 86. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Alpha- Antitrypsin Deficiency Treatment Segment by Type in 2021
Figure 2. Alpha- Antitrypsin Deficiency Treatment Segment by Application in 2021
Figure 3. Global Alpha- Antitrypsin Deficiency Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alpha- Antitrypsin Deficiency Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alpha- Antitrypsin Deficiency Treatment Revenue in 2021
Figure 8. By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2017-2028
Figure 12. US Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2017-2028
Figure 24. China Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)